Godavari Biorefineries

Mumbai, India Founded: 1939 • Age: 87 yrs Listed
Manufacturer of bio-based chemicals, sugar, alcohol, biofuels, power, and related products

About Godavari Biorefineries

Godavari Biorefineries is a publicly listed company based in Mumbai (India) founded in 1939. Manufacturer of bio-based chemicals, sugar, alcohol, biofuels, power, and related products. The company has 1,482 employees. Its Indian entity Godavari Biorefineries Limited reported revenue of β‚Ή2,000 Cr. Its focus areas include Conglomerates, Traditional Conglomerates, Energy and Bioenergy.

Company details

Founded in 1939 and based in Mumbai, India, operations are centered on the production of bio-based chemicals, sugar, rectified spirits, ethanol, biofuels, and power using sugarcane as the main feedstock. Research is conducted in sustainable farming, biomass transformation, product development, and process optimization to support diversification. Products are supplied to sectors including adhesives, lubricants, electronics, flavors, food and beverage, and pharmaceuticals.

  • Headquarters Mumbai, India
  • Employees 1,482
  • Stage Public
  • Sectors
    Energy & Utilities
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website godavaribiorefineries.com
  • Social LinkedIn X Facebook
  • Legal Name Godavari Biorefineries Limited
Key Metrics
  • Market Cap
    ₹1,173 Cr

    GODAVARIB · NSE

  • Share Price
    ₹226.08

    -1.39% today

  • Revenue
    ₹1,988 Cr

    FY 2025-26 · +6.3% YoY

  • EBITDA
    ₹95.98 Cr

    Margin 4.8%

  • Net Profit
    ₹33.63 Cr

    FY 2025-26 · +238.2% YoY

  • P/E (TTM)
    39.7x

    P/B 1.5x

  • ROE
    4.1%

    ROCE 6.4%

  • Debt / Equity
    0.65

    Interest cover 118.4x

  • Latest Funding Round
    $15M (USD), Unspecified

    May 2015

  • Investors
  • Employee Count
    1,482

Funding Insights of Godavari Biorefineries

  • Total Rounds 1
  • Last Round Unspecified β€” $15M
  • First Round $15M

    (May 2015)

  • Investors Count 1

All 1 funding rounds of Godavari Biorefineries with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2015$15MUnspecified––
Valuation history

1 investors in total: 1 institutional.

Investors in Godavari Biorefineries

Godavari Biorefineries has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Mandala Capital.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Tech & Offline focused VC firm investing in geographies such as India
mandala-capital.comEbene City, Mauritius
Premium access

Investor details for Godavari Biorefineries

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Godavari Biorefineries Limited (Godavari Biorefineries)

Godavari Biorefineries Limited is the primary company behind Godavari Biorefineries. The board of Godavari Biorefineries Limited currently have 12 directors; the longest-serving is Samir Shantilal Somaiya, appointed in 2007. 35 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Samir Shantilal Somaiya
DIN 00295458
Managing Director22 Jun 200719 yrs 4 moGodavari Biorefineries Limited
Lakshmi Kantam Mannepalli
DIN 07831607
Director28 Nov 20178 yrs 11 moGodavari Biorefineries Limited
Bhalachandra Raghavendra Bakshi
DIN 03538688
Whole-time director01 Jun 20188 yrs 5 moGodavari Biorefineries Limited
Hemant Luthra
DIN 00231420
Director27 Sep 20197 yrs 1 moGodavari Biorefineries Limited
Sangeeta Arunkumar Srivastava
DIN 00480462
Whole-time director01 Aug 20206 yrs 3 moGodavari Biorefineries Limited
Nitin Mehta
DIN 09174633
Director01 Jul 20215 yrs 4 moGodavari Biorefineries Limited
Suhas Uttam Godage
DIN 09227610
Whole-time director08 Sep 20215 yrs 2 moGodavari Biorefineries Limited
Raman Ramachandran
DIN 00200297
Director30 Nov 20232 yrs 11 moGodavari Biorefineries Limited
Kumar Desai
DIN 10729351
Director16 Sep 20242 yrs 1 moGodavari Biorefineries Limited
Nandan Dhananjay Mehta
DIN 07134249
Director30 Sep 20251 yr 1 moGodavari Biorefineries Limited
Sean Edward Reagan
DIN 01490812
Director30 Sep 20251 yr 1 moGodavari Biorefineries Limited
Dinesh
DIN 11675064
Whole-time director28 Sep 20261 moGodavari Biorefineries Limited

People of Godavari Biorefineries

1 people are tracked at Godavari Biorefineries (1 in leadership); the tracked headcount is 1,482.

NameRoleGroup
Managing DirectorLeadership
Premium access

Complete people profiles for Godavari Biorefineries

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Godavari Biorefineries

Godavari Biorefineries is a publicly listed company on the NSE with ticker symbol GODAVARIB in India, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date30 Oct 2024
  • Listed onBSE: 544279 · NSE: GODAVARIB
  • Listed entityGodavari Biorefineries Limited
  • Exchange sectorProcess industries
  • ISININE497S01012
  • Share price₹228.62 (+3.32% on the day) · 2026-10-14
  • Market capitalisation₹1,134 Cr
  • Price to earnings5,207.7
  • EPS (diluted, trailing year)₹0.04
  • Volume (last session)81,819

Financials of Godavari Biorefineries

Exchange-reported figures of Godavari Biorefineries Limited, the listed company behind Godavari Biorefineries (NSE: GODAVARIB).

Financial Highlights

FY 2025-26 Β· Consolidated
Revenue
₹1,988 Cr
+6.3% YoY
EBITDA
₹95.98 Cr
-7.4% YoY
Profit After Tax
₹33.63 Cr
+238.2% YoY
Net Worth
₹788 Cr
+0.8% YoY
Total Assets
₹1,332 Cr
+3.9% YoY
Total Debt
₹531 Cr
+8.4% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue1,9881,8701,6872,0151,7021,5381,459
Revenue growth+6.3%+10.9%-16.3%+18.4%+10.7%+5.4%-
EBITDA95.98104134146133158103
EBITDA margin+4.8%+5.5%+7.9%+7.3%+7.8%+10.3%+7.1%
Profit before tax4.57(1.55)12.4531.7532.0746.303.29
Net profit33.63(24.34)12.3920.2319.4526.380.31
Net profit margin+1.7%-1.3%+0.7%+1.0%+1.1%+1.7%+0.0%
EPS (β‚Ή)0.69(4.58)2.934.684.556.470.97
Balance sheet
Total assets1,3321,2811,1591,2281,1111,0281,029
Net worth788782501489473454427
Total debt531490655736636569589
Cash & bank32.1531.3832.5744.7846.7440.1444.06
Net working capital314393266331368280239
Cash flow
Cash from operations171(0.40)18519744.86130250
Cash from investing(163)(62.29)(43.99)(214)(47.67)(7.49)(22.60)
Cash from financing(5.74)63.83(151)28.435.95(121)(226)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue549558564460431533580447
Revenue growth (YoY)+27.5%+4.6%-2.7%+2.8%+34.2%+2.1%--
Other income0.532.059.292.063.520.749.253.56
EBITDA10.320.5286.2135.20(34.59)5.7611236.11
EBITDA margin+1.9%+0.1%+15.3%+7.7%-8.0%+1.1%+19.4%+8.1%
Depreciation15.2014.4913.9213.5513.5213.5012.8412.34
Interest15.3913.9311.3010.2112.3215.3013.0718.85
Profit before tax(19.74)(25.85)70.2813.50(56.91)(22.30)95.748.48
Tax(4.50)(6.53)17.395.24(15.31)(6.29)23.812.70
Net profit(15.24)(19.32)52.898.26(41.60)(16.01)71.935.78
EPS (β‚Ή)(2.98)(3.78)10.331.61(8.13)(3.13)14.051.31
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue1,9651,8531,6752,0001,6911,5261,449
Revenue growth+6.0%+10.6%-16.2%+18.3%+10.8%+5.4%-
EBITDA92.83100132138130155102
EBITDA margin+4.7%+5.4%+7.9%+6.9%+7.7%+10.1%+7.0%
Profit before tax1.52(5.42)10.3523.4729.1243.381.66
Net profit31.99(2.62)10.6512.5116.6723.81(1.32)
Net profit margin+1.6%-0.1%+0.6%+0.6%+1.0%+1.6%-0.1%
EPS (β‚Ή)0.24(0.52)2.522.863.895.860.60
Balance sheet
Total assets1,3111,2711,1531,2261,1111,0271,031
Net worth773773494484474458434
Total debt525488655739634564584
Cash & bank19.0520.6322.6624.1438.2533.9639.56
Net working capital277366241322365266226
Cash flow
Cash from operations173(1.43)19618540.43129240
Cash from investing(163)(60.94)(45.13)(217)(46.53)(8.49)(27.81)
Cash from financing(9.50)62.67(151)31.396.93(120)(211)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue537542562457423523576445
Revenue growth (YoY)+26.9%+3.6%-2.4%+2.6%+33.8%+1.4%--
Other income0.121.839.151.813.310.599.413.07
Total expenses528544477422459518465408
EBITDA9.19(1.83)85.5434.99(35.80)4.7011036.89
EBITDA margin+1.7%-0.3%+15.2%+7.7%-8.5%+0.9%+19.1%+8.3%
Depreciation15.1514.4313.8713.5213.4713.4512.7912.29
Interest15.1513.8111.2510.0112.2214.9712.8719.00
Profit before tax(20.99)(28.24)69.5713.27(58.18)(23.13)93.968.67
Tax(4.76)(6.96)17.165.17(15.56)(6.48)23.882.55

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 07 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue549558564460431533580447
Revenue growth (YoY)+27.5%+4.6%-2.7%+2.8%+34.2%+2.1%--
Other income0.532.059.292.063.520.749.253.56
EBITDA10.320.5286.2135.20(34.59)5.7611236.11
EBITDA margin+1.9%+0.1%+15.3%+7.7%-8.0%+1.1%+19.4%+8.1%
Depreciation15.2014.4913.9213.5513.5213.5012.8412.34
Interest15.3913.9311.3010.2112.3215.3013.0718.85
Profit before tax(19.74)(25.85)70.2813.50(56.91)(22.30)95.748.48
Tax(4.50)(6.53)17.395.24(15.31)(6.29)23.812.70
Net profit(15.24)(19.32)52.898.26(41.60)(16.01)71.935.78
EPS (β‚Ή)(2.98)(3.78)10.331.61(8.13)(3.13)14.051.31
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue1,9881,8701,6872,0151,7021,5381,459
Revenue growth+6.3%+10.9%-16.3%+18.4%+10.7%+5.4%-
Other income12.2116.6614.408.397.658.2113.65
Total expenses1,8921,7671,5531,8681,5691,3811,356
Employee cost0.0011711111093.2879.4679.13
EBITDA95.98104134146133158103
EBITDA margin+4.8%+5.5%+7.9%+7.3%+7.8%+10.3%+7.1%
Depreciation54.4950.0659.9350.0848.0347.1344.95
Interest49.1371.7975.5672.7960.4472.3868.74
Profit before tax4.57(1.55)12.4531.7532.0746.303.29
Tax1.0421.880.1512.1212.9719.17(0.78)
Net profit33.63(24.34)12.3920.2319.4526.380.31
Net profit margin+1.7%-1.3%+0.7%+1.0%+1.1%+1.7%+0.0%
EPS (β‚Ή)0.69(4.58)2.934.684.556.470.97
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital51.1851.1841.9441.9441.9441.9441.94
Reserves & surplus737731459448431412385
Shareholders' funds (net worth)788782501489473454427
Minority interest0.000.000.000.000.000.000.00
Secured loans44137754968458348990.30
Unsecured loans89.4111310652.3652.6680.16499
Total debt531490655736636569589
Total liabilities1,3321,2811,1591,2281,1111,0281,029
Assets
Gross block1,3471,2971,2351,193946945926
Net block866862850866667708735
Capital work in progress14837.3828.7817.0450.358.6516.69
Investments0.050.000.000.000.000.050.05
Inventories776740805519652424383
Sundry debtors114138190202173169126
Cash & bank balances32.1531.3832.5744.7846.7440.1444.06
Loans & advances69.9711448.7458.1310860.2391.83
Total current assets9921,0231,076824979693644
Total current liabilities677630811493611413405
Net working capital314393266331368280239
Total assets1,3321,2811,1591,2281,1111,0281,029
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash12.2511.1121.2710.036.895.255.25
Net cash from operating activities171(0.40)18519744.86130250
Net cash from investing activities(163)(62.29)(43.99)(214)(47.67)(7.49)(22.60)
Net cash from financing activities(5.74)63.83(151)28.435.95(121)(226)
Net change in cash3.001.14(10.16)11.253.141.640.52
Closing cash32.1531.3832.5744.7846.7440.1444.06
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+6.3%+10.9%-16.3%+18.4%+10.7%+5.4%-
EBITDA growth-7.4%-22.4%-8.7%+10.0%-15.7%+52.5%-
PBT growth+9998.0%--60.8%-1.0%-30.7%+1307.3%+9997.0%
Net income growth+238.2%-296.5%-38.8%+4.0%-26.3%+8409.7%-
Revenue CAGR (3Y)-0.4%+3.2%+3.1%+11.4%---
EBITDA CAGR (3Y)-13.1%-8.0%-5.4%+12.3%---
Profitability & leverage
Net income margin+0.2%-1.3%+0.7%+1.0%+1.1%+1.8%+0.3%
Return on capital employed+6.4%+5.8%+7.4%+8.9%+8.7%+11.5%+6.6%
Return on net worth+4.1%-3.7%+2.5%+4.1%+4.1%+6.2%+0.1%
Debt / equity0.650.891.401.431.301.311.36
Long-term debt / equity0.370.460.820.820.710.520.24
Interest cover118.39133.96102.6575.7071.2265.52117.75
Efficiency & per share
Fixed asset turnover1.501.481.391.881.801.641.58
Inventory turnover2.622.422.553.443.163.813.81
Debtors turnover15.7911.408.6110.759.9610.4311.61
EPS (β‚Ή)0.69(4.58)2.934.684.556.470.97
Dividend per share (β‚Ή)0.000.000.000.000.000.000.00
Book value per share (β‚Ή)154.03152.80119.37116.69112.77108.22101.84
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue537542562457423523576445
Revenue growth (YoY)+26.9%+3.6%-2.4%+2.6%+33.8%+1.4%--
Other income0.121.839.151.813.310.599.413.07
Total expenses528544477422459518465408
EBITDA9.19(1.83)85.5434.99(35.80)4.7011036.89
EBITDA margin+1.7%-0.3%+15.2%+7.7%-8.5%+0.9%+19.1%+8.3%
Depreciation15.1514.4313.8713.5213.4713.4512.7912.29
Interest15.1513.8111.2510.0112.2214.9712.8719.00
Profit before tax(20.99)(28.24)69.5713.27(58.18)(23.13)93.968.67
Tax(4.76)(6.96)17.165.17(15.56)(6.48)23.882.55
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue1,9651,8531,6752,0001,6911,5261,449
Revenue growth+6.0%+10.6%-16.2%+18.3%+10.8%+5.4%-
Other income11.4616.0413.817.536.877.1112.73
Total expenses1,8721,7531,5441,8621,5611,3721,347
Employee cost0.0011711111093.1079.2778.97
EBITDA92.83100132138130155102
EBITDA margin+4.7%+5.4%+7.9%+6.9%+7.7%+10.1%+7.0%
Depreciation54.3249.8659.6349.5847.5046.7344.68
Interest48.4571.6175.5172.5360.0371.6468.00
Profit before tax1.52(5.42)10.3523.4729.1243.381.66
Tax0.30(2.74)(0.22)11.4512.7918.84(0.88)
Net profit31.99(2.62)10.6512.5116.6723.81(1.32)
Net profit margin+1.6%-0.1%+0.6%+0.6%+1.0%+1.6%-0.1%
EPS (β‚Ή)0.24(0.52)2.522.863.895.860.60
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital51.1851.1841.9441.9441.9441.9441.94
Reserves & surplus722721452442432416392
Shareholders' funds (net worth)773773494484474458434
Secured loans436376549629533484277
Unsecured loans89.4111310610910180.08307
Total debt525488655739634564584
Total liabilities1,3111,2711,1531,2261,1111,0271,031
Assets
Gross block1,3441,2941,2321,190943942923
Net block865862849866666706733
Capital work in progress14837.7429.1417.0450.358.6516.69
Investments16.0916.0416.0416.0414.0414.0213.94
Inventories760733802517652423381
Sundry debtors104130182212176162121
Cash & bank balances19.0520.6322.6624.1438.2533.9639.56
Loans & advances68.4811347.9360.8811059.3590.62
Total current assets9519961,054815976678632
Total current liabilities675630813493612412406
Net working capital277366241322365266226
Total assets1,3111,2711,1531,2261,1111,0271,031
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash1.501.200.631.540.700.270.87
Net cash from operating activities173(1.43)19618540.43129240
Net cash from investing activities(163)(60.94)(45.13)(217)(46.53)(8.49)(27.81)
Net cash from financing activities(9.50)62.67(151)31.396.93(120)(211)
Net change in cash0.650.300.57(0.91)0.840.440.40
Closing cash19.0520.6322.6624.1438.2533.9639.56
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+6.0%+10.6%-16.2%+18.3%+10.8%+5.4%-
EBITDA growth-7.2%-24.1%-4.6%+6.4%-16.1%+52.2%-
PBT growth+9998.0%--55.9%-19.4%-32.9%+2513.3%+9997.0%
Net income growth+1321.0%-124.6%-14.9%-25.0%-30.0%+1903.8%-
Revenue CAGR (3Y)-0.6%+3.1%+3.2%+11.4%---
EBITDA CAGR (3Y)-12.4%-8.3%-5.2%+10.8%---
Profitability & leverage
Net income margin+0.1%-0.1%+0.6%+0.6%+1.0%+1.6%+0.2%
Return on capital employed+6.2%+5.5%+7.2%+8.2%+8.3%+11.2%+6.0%
Return on net worth+4.0%-0.4%+2.2%+2.5%+3.5%+5.5%-0.3%
Debt / equity0.660.901.421.431.291.291.71
Long-term debt / equity0.370.470.830.820.710.510.32
Interest cover125.81142.76104.8081.9872.9666.39119.44
Efficiency & per share
Fixed asset turnover1.491.471.381.881.791.641.65
Inventory turnover2.632.422.543.423.153.803.05
Debtors turnover16.8511.908.5010.309.9910.7911.15
EPS (β‚Ή)0.24(0.52)2.522.863.895.860.60
Dividend per share (β‚Ή)0.000.000.000.000.000.000.00
Book value per share (β‚Ή)151.05150.97117.87115.49113.08109.21103.47

Timeline of Godavari Biorefineries

3 dated milestones of Godavari Biorefineries across 85 years, from founding to its latest funding, stage changes and deals.

  1. Founded Godavari Biorefineries is founded.
  2. Funding First funding round of $15.0M.
  3. IPO Lists on the stock exchange (IPO).

Web traffic of Godavari Biorefineries

The website of Godavari Biorefineries (godavaribiorefineries.com) receives about 8.6K visits a month.

  • Monthly visits
    8.6K

    ▲ 19.6% vs previous month

Similar websites

Websites whose visitors overlap most with Godavari Biorefineries. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
somaiya.com
100%
3K#5,943,993View details
needsinfo.com
93%
#3,902,658View details
praj.net
81%
28.9K#455,374View details
sydneysolvents.com.au
65%
30.9K#828,268View details
avantgarde-india.com
avantgarde-india.com
64%
#2,042,059–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 9 similar websites and full traffic analytics for Godavari Biorefineries

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 9 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Renewable & Sustainable Energy

3 companies that operate in the same segment as Godavari Biorefineries (Renewable & Sustainable Energy) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Hybrid renewable energy solutions are provided for rural communities.
2008Patna, Bihar, IndiaUSD 73.99 MUSD 3.46 M294
Solar energy projects are developed for commercial and industrial clients.
2011Mumbai, Maharashtra, IndiaUSD 442.67 MUSD 166.51 M365
Manufacturer of solar PV modules
1990Mumbai, Maharashtra, IndiaUSD 111.38 MUSD 2.77 B8,690
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Godavari Biorefineries

GODAVARIB: Q2 REVENUE 5.5B RUPEES VS 4.23B (YOY)
Exchange Update β€’ 4 days ago
GODAVARIB: Q2 CONS NET LOSS 152.4 RUPEES VS LOSS 416M (YOY)
Exchange Update β€’ 4 days ago
Godavari Biorefineries: Co Mexican Patent Office Awards Patent For Using Compounds To Treat Viral Infections By Inhibiting V-ATPase Activity In Cells.
Exchange Update β€’ 1 month ago
Godavari Biorefineries: Co. Receives Patent Approval From Chinese Office For Viral Infection Treatment Compounds.
Exchange Update β€’ 1 month ago
Premium access

Complete news archive for Godavari Biorefineries

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Godavari Biorefineries

Godavari Biorefineries was founded in 1939 and raised its 1st funding round 76 years after it was founded.

Godavari Biorefineries is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Godavari Biorefineries has 1,482 employees.

The primary company behind Godavari Biorefineries, Godavari Biorefineries Limited, reported revenue of β‚Ή2,000 Cr for FY 2026, up 6% year on year.

Founded in 1939 and based in Mumbai, India, operations are centered on the production of bio-based chemicals, sugar, rectified spirits, ethanol, biofuels, and power using sugarcane as the main feedstock. Research is conducted in sustainable farming, biomass transformation, product development, and process optimization to support diversification. Products are supplied to sectors including adhesives, lubricants, electronics, flavors, food and beverage, and pharmaceuticals.

Yes, Godavari Biorefineries is publicly traded on NSE under the ticker symbol GODAVARIB.

Godavari Biorefineries has 1 investor. Key investors include Mandala Capital.

Godavari Biorefineries operates through Godavari Biorefineries Limited.

The legal entities of Godavari Biorefineries currently have 16 directors, including Lakshmi Kantam Mannepalli, Suhas Uttam Godage, Swarna Shivaji Gunware and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available